Navipharm Corporation   Report issue

For profit Phase 1 Phase 3
Founded: Hanoi Vietnam (2005)

Organization Overview

First Clinical Trial
2014
NCT02029625
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Navipharm Corporation